India Opens First Public Proton Therapy Center in Guwahati

The proposed facility is expected to significantly strengthen Assam's cancer-care infrastructure and provide patients in the Northeast access to advanced treatment facilities without having to [···]

Colorectal cancer in young people shows genetic and structural differences that may make it more aggressive and treatment-resistant than the cancer tends to be in older people.

High-grade serous ovarian cancer is an aggressive form of ovarian cancer, characterized in particular by high diversity among the cells that compose a given tumor. This intratumor heterogeneity is a [···]

Acute lymphoblastic leukemia (ALL), responsible for 75% of all pediatric leukemia diagnoses, requires immediate treatment- often a combination of chemotherapy, targeted therapy, immunotherapy and [···]

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.

/PRNewswire/ - Women with advanced or recurrent mismatch repair deficient (dMMR) endometrial cancer who were treated with immunotherapy alone lived longer...

Sac-TMT significantly improved progression-free survival and overall survival versus TPC in patients with advanced or recurrent endometrial cancer previously treated with platinum-based chemotherapy [···]

First-line pembrolizumab showed a statistically significant and clinically meaningful improvement in progression-free survival, with lower frequency of overall and grade 3 or above treatment-related [···]

TEHRAN - Nanotechnology is opening new avenues for breast cancer treatment by improving drug delivery, overcoming resistance to chemotherapy, and reducing damage to healthy cells. Pakistani [···]